Dr. Margaret Wasilewski

Dr. Margaret Wasilewski has a strong background in pharmaceuticals and clinical development. Dr. Margaret is currently the Chief Medical Officer at Pulmatrix Inc., where they lead clinical strategy, development, and commercialization of novel medicines using respiratory delivery technology. Prior to this, they served as President of ID Remedies LLC and Summit Therapeutics, as well as holding leadership positions at Shire, Tetraphase Pharmaceuticals, Targanta Therapeutics, and ID Remedies LLC. Dr. Margaret'sexperience spans from 2003 to the present, demonstrating their expertise in medical sciences and clinical development.

Dr. Margaret Wasilewski has an extensive education background. Dr. Margaret completed their Bachelor's degree in Chemistry Biochemistry at Rutgers University from 1975 to 1980. Dr. Margaret then pursued a Master's degree in Nutrition at the University of California, Berkeley, graduating in 1983.

Afterwards, Dr. Wasilewski attended Tufts University School of Medicine, earning their Doctor of Medicine (MD) degree. The exact duration of their medical degree is not specified.

Continuing their medical education, they engaged in a Fellowship for Infectious Diseases and Clinical Pharmacology at the University of California, San Francisco - School of Medicine. This took place from 1991 to 1994.

Later in their career, Dr. Wasilewski pursued a Master of Business Administration (MBA) at Indiana University - Kelley School of Business. Dr. Margaret completed their MBA from 2009 to 2015.

In terms of additional certifications, Dr. Wasilewski holds an Indiana Medical License, obtained through the Indiana Medical Board. The specific date of when they obtained this license is not provided.